Taiwanese Health-Tech Firms Test U.S. Market Integration in Dallas

The exhibition highlighted a diverse range of technologies, from hospital-grade AI and remote monitoring platforms to advanced rehabilitation hardware. For many participants, the primary hurdle remains transitioning products developed within Taiwan’s digitized healthcare system into a U.S. market governed by different reimbursement models, clinical workflows, and patient data requirements. Institutions like Taichung Veterans General Hospital and Chang Gung Memorial Hospital, which act as both developers and clinical users, are now actively seeking international partners to validate their AI models across broader, non-Asian patient populations.

While companies like Onyx Healthcare leverage an established decade-long presence in the U.S. to scale their existing footprint, others are navigating the initial stages of FDA clearance and local service deployment. The pavilion underscored that successful entry requires more than just technical precision; it demands a comprehensive ecosystem of local installation, caregiver training, and software integration. As TAITRA Chairman James C. F. Huang noted, the initiative aims to move beyond simple product displays toward sustained industrial co-innovation, positioning Taiwan as a critical infrastructure partner capable of scaling medical technology from concept to clinical reality.